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ATTITUDES OF CLINICIANS TOWARDS CARDIAC SURGERY AND TRISOMY 18
Meagan E. Kaulfus, B.S.
Advisory Professor: Rebecca Carter, M.S.
ABSTRACT
Trisomy 18 is an autosomal trisomy characterized by minor to major birth defects,
severe disabilities, and high rates of pre- and neonatal mortality. Interventions for these
infants have traditionally been withheld with focus instead on palliative support. The
issues and attitudes surrounding surgical treatment of congenital heart defects, which
occur in approximately 90% of infants with trisomy 18, is of our study’s interest as recent
literature has indicated that cardiac surgery is being performed and may lead to improved
survival compared to palliative care. In this study, the attitudes of clinicians of multiple
specialties towards cardiac surgery for infants with trisomy 18 was evaluated along with
approaches used by cardiac surgeons to determine candidates for surgery. Of the 378
participants, 48% felt it was appropriate to discuss the option of cardiac surgery. Ethical
considerations and insufficient outcome data were the most agreed upon reasons for not
offering cardiac surgery in majority of clinicians. Overall, prenatal physicians were more
likely to disagree with offering cardiac surgery than postnatal physicians and genetic
counselors. Trisomy 18 not being uniformly lethal was the most agreed upon justification
among clinicians in support of offering surgery, followed by respect for expression of
parental wishes. Cardiac surgeons were more likely to perform surgery on less complex
heart defects in the absence of additional anomalies or presence of less severe anomalies.
Results from this study do not seek to suggest uniform care for these infants, but aim to
promote discussion and collaboration among clinicians to improve patient care.
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INTRODUCTION
Trisomy 18, or Edwards syndrome, is an autosomal trisomy involving an extra copy of
chromosome 18. Following Down syndrome, trisomy 18 is the second most common autosomal
trisomy with a quoted prevalence of 1 in 3,000 to 1 in 8,000 live births. Children with trisomy
18 have minor to major birth defects, severe psychomotor and cognitive disabilities, and an
increased risk for pre- and postnatal mortality1, 2. Due to the presence of multiple anomalies, it is
estimated that approximately 5-10% of live born infants with trisomy 18 live to the first year of
life3. A more recent population-based study reported a one-year life expectancy of 13.4%,
however this might be attributed to more aggressive medical interventions being increasingly
offered4. Survival past one year of life and rarely into the second decade of life has been
reported with those individuals experiencing profound cognitive and psychomotor delays5-7.
Individuals with mosaic trisomy 18 or partial trisomy 18, which make up approximately 7% of
cases of trisomy 18, may display a less severe phenotype and a lower mortality rate compared to
non-mosaic trisomy 182, 8. Because of the high mortality associated with non-mosaic trisomy 18,
medical care has traditionally been palliative rather than aggressive, particularly regarding the
surgical repair of birth defects.
Out of the many birth defects seen in infants with trisomy 18, the issues and attitudes
surrounding surgery on congenital heart defects (CHDs) is one that remains particularly
controversial in the medical literature. CHDs are found in approximately 90% of infants
affected with trisomy 18, the most common being ventricular septal defects (VSD), atrial septal
defects (ASD) and patent ductus arteriosi (PDA)9-11 while 10% have more complex CHDs12.
Heart failure secondary to an unrepaired cardiac defect is considered one of the major causes of
deaths in infants with trisomy 18 along with respiratory failure or central apnea1, 2, 13. Due to the
co-morbidities of this condition, aggressive interventions such as cardiac surgery have
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historically been strongly discouraged14. Numerous studies15-18 have provided justification for
palliative approaches over surgery, raising concerns such as heart surgery being a poor
allocation of the institution’s time and resources, harm to the infant during the recovery process
such as pain during or post-surgery, limited maternal bonding, harsh environmental stressors,
and disturbed sleep wake cycles. Other expressed considerations involve the ethical concerns
surrounding surgery for infants with trisomy 18 such as nonmaleficence, beneficence, and
justice, the quality of life after surgery, lack of clarity as to whether cardiac surgery truly
improves prognosis, and potentially providing false or unrealistic expectations for the families.
Despite these views traditionally discouraging surgical intervention, in the last decade
numerous studies11, 19-22 have described outcomes following cardiac surgery on infants with
trisomy 18, most frequently on VSDs, ASDs, and PDAs demonstrating seemingly favorable
results. One study22 found that children with trisomy 18 had a two-year survival rate of 45%
after cardiac surgery and another study23 through the Pediatric Cardiac Care Consortium
reported an 86% hospital survival rate in infants with trisomy 18 following surgical repair of a
CHD. While there are published recommendations regarding the importance of conversations
between clinicians and families regarding the option of cardiac surgery24, there is an overall lack
of agreement in the published literature for recommendations of cardiac surgery over palliative
approaches for moderately complex cardiac defects in infants with trisomy 1823, 25. Although
numerous studies do claim cardiac surgery potentially helps negate cardiac-related death and
has the potential to improve the survival length of infants with trisomy 18 compared to infants
that receive palliative care, many argue that more data demonstrating there is a clinical benefit
to cardiac surgery needs to be published before generalizations can be made on whether or not
to offer surgery15, 20, 21, 26, 27. Furthermore, it is important to carefully consider the limitations of
the data available on the survival statistics of infants who undergo cardiac surgery. Confounders
2

may include selection bias of infants who undergo cardiac surgery as they are often selected
based on less severe heart defects, absent or mild additional anomalies, and older ages. Most
authors on both sides this subject agree that it is unrealistic to conclude that there will be a
straightforward answer to this question, as each infant with trisomy 18 and his or her family will
need to be considered on an individual basis, not grouped into a syndrome or diagnosis12, 27-31.
Ultimately, the decision for an infant to undergo cardiac surgery is controversial and requires
careful consideration and a thorough understanding by involved clinicians of the benefits and
limitations of such intervention.
As this topic has increasingly gained interest within the medical community, research
has been performed examining the attitudes of physicians regarding the care and management of
infants with trisomy 18. Two different studies on the opinions of neonatologists towards
neonatal resuscitation for infants with trisomy 18 found that the expressed wishes of the parents
largely drove the decision to perform resuscitation, a finding in favor of parental autonomy as
opposed to a strict, palliative care approach32, 33. Other studies reinforce this, reporting that the
majority of physicians, including obstetricians and gynecologists (OBGYN), maternal fetal
medicine specialists (MFM), neonatologists, medical geneticists, and cardiologists, identified
that they were likely to respect parental autonomy regarding management decisions in
conditions such as trisomy 18 rather than making management decisions based solely on the
diagnosis itself24, 34-37. While some consistencies have been found among physicians, these and
other studies have further identified differences in opinions among and between specialties
regarding the care and management of infants with trisomy 18. For example, in one study36
cardiologists were more likely to recommend interventions including cardiac surgery for infants
with trisomy 18 than neonatologists or medical geneticists. Conversely, another study37
surveying cardiologists in Canada, respondents were more likely to recommend palliative care
3

and medical treatment of symptoms, not surgical repair of cardiac defects. In another, pediatric
pulmonologists were more likely to offer interventions such as full code resuscitation and
cardiac surgery compared to neonatologists38. These differing opinions among physicians
suggests there is not a uniformly accepted standard of care for infants with trisomy 18.
Therefore, decision-making surrounding the care and management of these infants should be
considered on an individual basis and should not be grouped into a syndrome or diagnosis
without consideration of the individual infant24, 35-37. As many clinicians are involved in the preand postnatal care of infants with trisomy 18 and the discussions with families, additional
research is warranted to add to previously described clinicians’ attitudes towards this
controversial topic in the interest of improving understanding of clinical approach and
promoting consistency. When trisomy 18 is diagnosed prenatally, the patient has the option to
continue or terminate the pregnancy. For those who decide to continue the pregnancy,
discussions of prenatal and postnatal management options should take place between the patient
and her healthcare team. These conversations may involve the following specialists: the
OBGYN likely to be involved with the delivery process, MFM, neonatologist, prenatal and
pediatric genetic counselor and medical geneticist, pediatrician, cardiac specialist in the event
surgery is being considered, and depending on the needs of the family, sometimes a chaplain,
clinical social worker, or home care providers such as nurses and therapists30. While all of these
clinicians are important in the care of families with infants of trisomy 18, our study chose to
focus on the attitudes of OBGYNs, MFMs, neonatologists, medical geneticists, genetic
counselors, cardiologists, and cardiac surgeons.
The topic of cardiac surgery for infants with trisomy 18 is undeniably a very
complicated subject in the medical literature and clinical practice, as clinicians strive to provide
high standards of patient care while balancing allocation of resources, parental autonomy, and
4

the best interest of the patient. As no official recommendations exist, guidance for clinicians
involved in the pre- and postnatal care of these infants remains limited. Thus, the current
discussions with the families may be based on outdated literature or simply lack of knowledge
of the available options. Some studies point to the effectiveness and potential benefit of cardiac
surgery, while others state that such data is far too limited to draw conclusions about improved
outcomes. Such discrepancies ultimately lead to a lack of consistency among clinicians
throughout the country and the care given to patients. We aim to improve understanding of why
and how some clinicians choose to incorporate the options of cardiac surgery into their
discussion, and why others do not, as well as variables that cardiac surgeons may view as
influential when considering the surgical candidacy of a patient. By exploring these attitudes,
we hope to further stimulate conversations within and among specialties, members of the
healthcare team, and perhaps eventually professional societies to promote consistency in the
discussions among families and their healthcare team to improve patient care. Thus, this study
aims to describe clinicians’ attitudes towards cardiac surgery and infants with trisomy 18 and
additionally to identify approaches used by cardiac surgeons in determining surgical candidates.
METHODS
Study Participants
Clinicians in the following specialties were eligible for participation: OBGYNs, MFMs,
neonatologists, medical geneticists, genetic counselors, cardiologists, and cardiac surgeons. This
study was approved by the Institutional Review Board of the University of Texas MD Anderson
Cancer Center UTHealth Graduate School of Biomedical Sciences (HSC-MS-16-0454). Genetic
counselors were recruited via a survey link electronically distributed to members of the National
Society of Genetic Counselors listserv. Physicians were recruited through genetic counselors
affiliated with fetal centers across the United States. Genetic counselors disseminated the survey
5

link by emails to the eligible physicians at their respective institutions. Additionally, physicians
were recruited through electronic distribution of the survey link via membership of the North
American Fetal Therapy Network. Lastly, physicians that were reached by the methods listed
above were given approval to distribute the survey link to their colleagues in the eligible
specialty that were not already captured by previously implemented data collection methods.
The study consent was present at the beginning of the survey on Qualtrics in the form of a letter
of invitation. Completion of the survey was considered consent. Specific recruitment dates
varied by data collection method, with responses collected from August to December 2016.
Anonymous Survey
The survey consisted of questions regarding demographics of the clinicians, general
questions about knowledge of and experience with patients with trisomy 18, and clinicians’
attitudes towards reasons against and for offering cardiac surgery for infants with trisomy 18.
Cardiac surgeons were additionally asked questions about the types of heart defects on which
they would perform surgery on infants with trisomy 18 and if the presence of additional
anomalies would impact their decision to perform such surgery. Participants were asked to
respond to the questions in this survey specifically for non-mosaic trisomy 18. The question
formatting consisted of multiple choice, “agree” or “disagree,” and Likert scale questions on a
scale of 1 (strongly disagree) to 5 (strongly agree) including the option of “neutral.” For the
purpose of data analysis and throughout this paper, clinicians who indicated they “strongly
disagree” or “disagree” with the statement have been grouped together and will be referred to as
“disagreeing,” while clinicians who indicated they “strongly agree” or “agree” with the
statement will be referred to as “agreeing.” Free text boxes were available for additional
comments which were included to obtain exploratory data that may lead to hypothesis-building
and future studies. A formal validated measure was not used as survey questions were uniquely
6

developed by the authors for the purpose of this study and were reviewed by clinicians in each
of the specialties of interest.

Data Analysis
Responses were managed using Qualtrics and were stored at the McGovern Medical
School. STATA 13.1 statistical software was used for data analysis. Descriptive statistics were
used to describe the results of all clinicians, while quantitative statistical comparisons were
analyzed between the following clinician types: prenatal physicians (including OBGYNs and
MFMs), postnatal physicians (including neonatologists, medical geneticists, cardiologists, and
cardiac surgeons), and genetic counselors. This latter comparison was chosen based on the
substantial number of genetic counselor respondents compared to other specialties to account
for the difference in number of participants. Statistically significant relationships for Likert scale
variables were determined by analyzing the three comparison groups using Kruskal Wallis tests
and between two groups using Mann Whitney ranked sum tests. Categorical variables were
compared using contingency tests (Fisher exact or Chi-square). A p-value of <0.05 was
considered statistically significant.
Free responses were individually reviewed and classified for common themes that were
presented by the clinicians. These classifications were independently performed by two authors
(MK and RC) and represented a degree of agreeability. Secondary qualitative assessments were
made of these responses to identify themes and topics that were raised by clinicians.
RESULTS
A total of 378 clinicians participated in this survey which included 253 genetic
counselors, 72 MFMs, 22 medical geneticists, 14 neonatologists, 8 cardiologists, 6 cardiac
surgeons, and 3 OBGYNs. Participants who completed only the demographic section of the
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survey were excluded from data analysis. Response rate was difficult to determine due to the
multiple methods of data collection and the independent discretion of the genetic counselors that
were asked to disseminate the survey to physicians associated with their institution.

Demographics
The majority of clinicians were female (86%), Non-Hispanic white (91%) working in
university based hospital practices (58%) or non-university based hospital practices (29%).
Forty-five percent of clinicians were between 25-34 years of age with ages ranging from 18-24
through 65 or older. The majority (69%) of clinicians reported they see 1-5 patients with
trisomy 18 per year. Of the clinicians who indicated they see at least one patient with trisomy 18
on average per year, 50% reported they discussed the option of cardiac surgery with at least one
of their patients, while 46% indicated they did not have the discussion with any of the patients
with trisomy 18. Please see Table 1 below for additional demographic information.
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Table 1: Demographics of clinicians (n=378)
Age (n=371)
18-24
25-34
35-44
45-54
55-64
65 or older

n
20
168
84
63
27
9

(%)
(5)
(45)
(23)
(17)
(7)
(3)

Gender (n=375)
Female
Male

n
323
52

(%)
(86)
(14)

Ethnicity (n=378)
Non-Hispanic white
Asian
African American
Other

n
345
11
4
18

(%)
(91)
(3)
(1)
(5)

n

(%)

114
98
75
66
17

(31)
(27)
(20)
(18)
(4)

n

(%)

218
108
30
19

(58)
(29)
(8)
(5)

Region of the United
States (n=370)
South
Midwest
West
Northeast
Other
Setting of Practice
(n=375)
University-based
Non-university based
Private practice
Other

Specialty (n=378)
Genetic counselors
Prenatal
Pediatrics
Prenatal/Pediatrics
Other (cancer, lab, industry, etc)
Maternal fetal medicine specialists
Medical geneticists
Neonatologists
Cardiologists
Cardiac surgeons
Congenital heart surgery
Obstetricians and gynecologists

n
253
149
55
36
13
72
22
14
8
6
6
3

(%)
(67)
(59)
(22)
(14)
(5)
(19)
(6)
(4)
(2)
(1)
(100)
(1)

Years in Current Specialty (n=378)
Less than 5 years
5-10 years
11-15 years
16-20 years
More than 20 years

n
168
72
46
35
57

(%)
(45)
(19)
(12)
(9)
(15)

n

(%)

134
86
40
35
81

(36)
(23)
(10)
(9)
(22)

n

(%)

40
262
59
15
2

(11)
(69)
(16)
(4)
(0)

n

(%)

149
156
5

(46)
(49)
(2)

4
7

(1)
(2)

Years since medical/genetic counseling
degree (n=376)
Less than 5 years
5-10 years
11-15 years
16-20 years
More than 20 years
Patients seen (on avg/year) with
dx of non-mosaic trisomy 18 (n=378)
None
1-5
6-10
11 or more
Not sure
Patients (on avg/year) with non-mosaic
trisomy 18 with whom cardiac surgery was
discussed (n=321)
None
1-5
6-10
11 or more
Not sure
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General Knowledge and Attitudes Towards Trisomy 18
Sixty-nine percent of clinicians accurately answered that 5-10% of infants with trisomy
18 survive beyond one year when asked about the average postnatal lifespan. More prenatal
physicians (36%) inaccurately recalled the average postnatal lifespan to be less than 1% survive
beyond one year compared to postnatal physicians (32%) genetic counselors (23%). Nearly half
of all clinicians (n=357, 48%) agreed that discussing the option of cardiac surgery is
appropriate, while thirty percent of clinicians disagreed. When stratified by clinician type
(prenatal physicians vs. postnatal physicians vs. genetic counselors), there was a significant
trend (p<0.001) where postnatal physicians were more likely to agree (n=48, 44%) compared to
prenatal physicians (n=73, 29%) about the appropriateness of discussing the option of cardiac
surgery. Fifty-nine percent of all clinicians (n=356) agreed that the discussion of cardiac surgery
is within their scope of practice. When asked if insurance companies should cover the cost of
cardiac surgery, overall about a third each of all clinicians agreed (30%), disagreed (33%), or
were neutral (37%). Prenatal physicians were statistically more likely to disagree about
insurance coverage for surgery (n=73, 59%) than postnatal physicians or genetic counselors,
23% and 27% respectively (p<0.001).
Clinicians were asked about their attitudes towards the following terms being used to
describe individuals with trisomy 18: vegetative, incompatible with life, lethal anomaly, and
life-limiting. Most clinicians disagreed with the use of vegetative (n=356, 68%), while across all
specialties most clinicians agreed with the term life-limiting (n=357, 93%). When stratified by
clinician type, more prenatal physicians agreed with use of the term vegetative (n=73, 38%)
compared to postnatal physicians (n=48, 27%) and genetic counselors (n=235, 10%) although
the differences were not statistically significant. Prenatal physicians were statistically more
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likely to agree with use of the term “incompatible with life” (n=73, 52%) compared to postnatal
physicians (n=48, 29%,) and genetic counselors (n=235, 32%) (p=0.026).
General Questions Towards Cardiac Surgery for Infants with Trisomy 18
Clinicians were asked whether they agreed or disagreed with statements regarding the
end benefit of cardiac surgery for infants with trisomy 18. Over half of all clinicians agreed with
the following potential benefits: parental autonomy is respected (n=345, 91%), potential
extension of time with their infant (n=344, 81%), and the potential for improved quality of life
(n=339, 51%). Thirty-seven percent of clinicians (n=345) felt there was “no end benefit” in
performing cardiac surgery. When stratified by clinician type, prenatal physicians (58%) were
more likely to agree that cardiac surgery has “no end benefit” than other clinician types
(p<0.001). Prenatal physicians were statistically more likely to disagree that cardiac surgery has
the potential to extend the time with their infant (37%, p<0.001) and could potentially improve
the infant’s quality of life (68%, p=0.002). With the option to select all that apply, clinicians
(n=347) indicated that first hand clinical experiences (64%), medical/genetic counseling school
training (59%), discussions with colleagues (57%), and parental autonomy (42%) influence their
recommendations towards cardiac surgery. Thirty percent (n=287) of clinicians reported their
current approach with patients includes discussing cardiac surgery if brought up by parents,
emphasizing it may be an option, and providing a referral to cardiac surgery, while 28%
(n=295) indicated their current approach includes discussing if brought up by parents but
emphasizing surgery is discouraged. Forty-six percent (n=347) of clinicians indicated their
approach has not changed over time meaning clinicians who have always discussed the option,
still discuss, while clinicians who have not discussed the option, still do not discuss. The 54% of
clinicians whose approach has changed over time indicated it was due to clinical experiences
(21%), discussion with colleagues (21%), and new literature on the topic (12%). Of the formerly
11

mentioned 48% of clinicians (n=347) who felt cardiac surgery is appropriate to discuss with
patients, 74% indicated their approach would be to discuss surgery and/or refer the patient to
cardiac surgery. Of the clinicians who felt the discussion of cardiac surgery was inappropriate
(30%), 11% indicated they would still discuss surgery and/or refer the patient to cardiac surgery.
Attitudes Regarding Considerations in Offering Cardiac Surgery
Over half of all clinicians (n=346-356) agreed with the following reasons as
justifications to not offer cardiac surgery for infants with trisomy 18: condition has a general
unacceptably high mortality (71%), high perioperative mortality (65%), insufficient outcome
data and on risks and benefits of surgery (59%), parents alone should judge risk-benefit ratio of
surgery (58%), provides false hope for the family (56%), causes infant pain and suffering
(54%), and surgery will not improve the infant’s quality of life (51%) (Figure 1).

Figure 1: Clinician attitudes towards considerations surrounding cardiac surgery for
infants with trisomy 18 (n=346-356)
General unacceptably high mortality

71%

High perioperative mortality

13%

65%

16%

24%

11%

Insufficient outcome data

59%

Parents alone should judge risk-benefit ratio

58%

Provides false hope for family

56%

20%

24%

Causes infant pain and suffering

54%

23%

23%

29%

12%

19%

23%

Will not improve quality of life

51%

23%

26%

Deserve access to same interventions

49%

25%

26%

Inappropriate allocation of time and resources

47%

Can have a general acceptable quality of life

44%

Cost to society is burdensome

38%

Expression of parental wishes

37%

Not uniformly lethal
Should Not Offer Surgery

26%

28%

Neutral

27%

36%

20%

26%

36%

19%
19%

44%
53%

Should Offer Surgery
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When clinicians were asked about societal costs of cardiac surgery for these infants, 47% of
clinicians agreed that surgery should not be offered due to surgery being an inappropriate
allocation of the institution’s time and resources and 38% agreed that the cost of surgery to
society is burdensome as reasons not to offer cardiac surgery. Overall when stratified by
clinician types, prenatal physicians tended to be more likely to indicate surgery should not be
offered compared to postnatal physicians and genetic counselors, who tended to have more
equal distributions between agreeing, disagreeing, and neutral (Table 2).

Table 2: Comparison of attitudes towards considerations in offering cardiac surgery by
clinician type (prenatal physicians (n=75), postnatal physicians (n=50), genetic counselors
(n=253))

Reasons Regarding Offering Cardiac Surgery
*General unacceptably high mortality (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
*High perioperative mortality (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
Insufficient outcome data (p=0.262)
Prenatal physicians
Postnatal physicians
Genetic counselors
Parents alone should judge risk-benefit ratio (p=0.319)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Provides false hope for family (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
Causes infant pain and suffering (p=0.086)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Will not improve quality of life (p=0.021)
Prenatal physicians
Postnatal physicians
Genetic counselors

Should Not Offer
Surgery

Neutral

Should Offer
Surgery

85%
54%
71%

5%
17%
14%

10%
29%
15%

64%
42%
69%

32%
31%
21%

4%
27%
10%

50%
54%
63%

43%
17%
26%

7%
29%
11%

64%
78%
52%

13%
7%
24%

23%
15%
24%

67%
61%
52%

18%
10%
22%

15%
29%
26%

62%
58%
51%

20%
19%
24%

18%
23%
25%

58%
54%
48%

27%
19%
22%

15%
27%
30%
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*Deserve access to same interventions (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Inappropriate allocation of time and resources (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Can have a general acceptable quality of life (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Cost to society is burdensome (p<0.001)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Expression of parental wishes (p=0.034)
Prenatal physicians
Postnatal physicians
Genetic counselors
*Condition is not uniformly lethal (p=0.007)
Prenatal physicians
Postnatal physicians
Genetic counselors

71%
67%
39%

20%
13%
29%

9%
20%
32%

76%
32%
42%

13%
33%
28%

11%
35%
30%

62%
44%
39%

34%
26%
38%

4%
30%
23%

68%
28%
31%

18%
36%
26%

14%
36%
43%

57%
59%
27%

20%
19%
18%

23%
22%
55%

53%
37%
19%

17%
26%
18%

30%
37%
63%

One exception was in regard to insufficient research on risks and benefits. Genetic counselors
were more likely to agree (63%) than prenatal (50%) and postnatal physicians (42%) with
insufficient outcome data as a reason to not offer cardiac surgery. The differences were
statistically significant between prenatal physicians, postnatal physicians, and genetic
counselors for all provided considerations regarding cardiac surgery with the exception of
insufficient outcome data, the risks and benefits of surgery, parents alone should judge the riskbenefit of surgery, and surgery causes the infant pain and suffering. Please see Table 2 for
additional information.
Fifty-three percent (n=347) of clinicians across all specialties agreed that trisomy 18 not
being uniformly lethal is a reason to offer cardiac surgery (Figure 1). This was the sole
consideration on which the majority of all clinicians agreed in support of offering surgery. Of all
clinicians, 44% agreed that surgery should be offered if parents express their wish to have
“everything done” for their child. When stratified into clinician type, genetic counselors were
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twice as likely to agree (55%) with surgery being offered due expression of parental wishes
compared to prenatal and postnatal physicians, 23% and 22% respectively (p=0.034). Overall
26% of clinicians felt surgery should be offered because infants with trisomy 18 deserve access
to the same interventions as chromosomally typical infants compared to 49% who disagreed;
further analysis revealed that genetic counselors were statistically more likely to agree (32%)
with this statement as justification for offering surgery than prenatal and postnatal physicians
(9% and 20% respectively) (p<0.001). Twenty percent of clinicians agreed that individuals with
trisomy 18 having an acceptable quality of life was a reason to offer cardiac surgery, while 36%
were neutral. Postnatal physicians and genetic counselors were more likely to agree (30% and
23%) with this statement as a justification to offer surgery than prenatal physicians (4%)
(p<0.001).
Cardiac Surgeon Approaches to Determining Candidates for Cardiac Surgery
Four out of six cardiac surgeons reported they had performed cardiac surgery on at least
one infant with trisomy 18; the two cardiac surgeons that had not performed surgery indicated
they would be willing to do so. Most cardiac surgeons indicated they would be willing to
perform surgery on an infant with trisomy 18 for the following heart defects: VSD (5/6), PDA
(5/6), coarctation of the aorta (5/6), and ASD (4/6) while none of the cardiac surgeons indicated
they would be willing to perform surgery on infants with trisomy 18 and hypoplastic left heart
syndrome (Table 3).
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Table 3: Cardiac surgeons’ willingness to perform surgery on infants with trisomy 18
depending on the type of heart defect and the presence of additional anomalies (n=6)
Type of Heart Defect
Ventricular septal defect
Patent ductus arteriosus
Coarctation of the aorta
Atrial septal defect
Tetralogy of fallot
Pulmonary stenosis
Atrioventricular septal defect
Transposition of the great arteries
Double outlet right ventricle
Hypoplastic left heart syndrome
Anomalies Present in Addition
to Heart Defect
Clubfoot
Polydactyly
Cleft lip +/- palate
Spina bifida
Omphalocele
Esophageal atresia
Diaphragmatic hernia

Willing to Perform Surgery (n)
5
5
5
4
3
3
2
1
1
0
Willing to Perform Surgery (n)
5
5
4
3
2
1
0

In an infant with trisomy 18 with a heart defect described to be of mild to moderate complexity,
most cardiac surgeons were still willing to perform surgery in the presence of additional
anomalies including clubfoot (5/6), polydactyly (5/6), and cleft lip with or without cleft palate
(4/6). Fewer reported willingness to perform surgery as the severity of the anomaly increased,
with no cardiac surgeons (0/6) willing to perform surgery with the additional finding of a
diaphragmatic hernia. All cardiac surgeons selected gestational age, birth weight, the
complexity of the heart defect, and presence of additional anomalies as influential factors in
determining appropriate candidates for surgery. The gender of the infant was found to be the
least influential factor in determining candidacy for surgery (Figure 2).
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Figure 2: Cardiac Surgeons’ attitudes towards the influence of other factors in their
willingness to perform cardiac surgery on infants with trisomy 18 (n=6)
Gestational age

6

Birth weight

6

Complexity of heart defect

6

Presence of additional anomalies

5

Parental request

1

4

Recommendation of bioethics

3

Apgar scores

3

Support of other team members

2

Gender

2
0

1

1

2
1

1
2

3

1
4

1

2

3

4

5

6

Number of Cardiac Surgeons
Very influential

Somewhat

Not at all influential

Half of cardiac surgeons (3/6) indicated their decision to perform cardiac surgery on infants
with trisomy 18 is made on a “case by case basis” while the other half (3/6) indicated the
decision is made at the discretion of the attending team.
Free responses
Of the clinicians in our study, 29% left free responses (n=108). A total of 158 free
responses were recorded, as many clinicians left more than one free response. A topic that was
brought up most by clinicians (approximately 40%) in the free responses was that the
appropriateness of offering cardiac surgery for an infant with trisomy 18 should depend on the
clinical picture of the infant.
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“Decisions about intervention should be made on the individual child's situation, not a
blanket decision based on chromosomal diagnosis.” – Medical geneticist
“I feel that the decision to pursue cardiac intervention for patients with [trisomy 18] is a
very personal decision that should be made collaboratively with both the patient and the care
team. If the patient is relatively stable and is healthy enough to undergo cardiac intervention
without almost definite outcomes of death during surgery, the family should be offered
intervention. The value of added days, weeks or years of life expectancy as well as the quality of
a child's life should not be determined by care providers alone but together with the family.” Neonatologist
“[Performing surgery] depends on the surgery. If it is "palliative”… to relieve
symptoms and/or [only] one surgery...then it might be fine. For complex lesions…surgery
should not be offered.” – Cardiologist
Another frequently encountered topic pertained to the parents being adequately informed of the
risks and benefits of surgery before making a decision.
“If extensive counseling is performed and the parents appear to understand the
limitations of such care, and the care is available.. it may be appropriate to have this
discussion.” – MFM
“Parents should be provided with factual information and have access to a counselor
who can guide them through the process of making a decision that fits with what they want for
their child.” – Medical geneticist
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“I feel like a thorough discussion with the parents regarding why they wish for cardiac
intervention is ESSENTIAL.” – Genetic counselor
Many clinicians brought up the overall cost of surgery including societal burden and the
emotional and financial cost to the family.
“[Cardiac] surgery could diminish any quality time the parents could expect with these
very disabled children for no real expectation of long term benefit.” – MFM
“Raising the unnecessary cost of medical care to society just because you can is a
disservice to society.” – MFM
“What cardiac surgery does in many cases is to prolong the life in the hospital at the
expense of the family.” – Medical geneticist
Lastly, clinicians indicated that cardiac surgery may potentially improve the outcome of the
infant with trisomy 18.
“There may be some instances where palliative procedures reduce suffering but do not
necessarily prolong life, which may be an acceptable intervention.” – MFM
“Many of the cardiac defects result in increased work of breathing which results in
respiratory distress. Repairing these can alleviate some degree of suffering [for the infant]” –
Cardiologist
“[Surgery] could optimize quality of life for the time the infant has available.” –
Cardiac surgeon
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DISCUSSION
The appropriateness of offering cardiac surgery to families of infants with trisomy 18 is
undoubtedly complex and has been met with a wide range of opinions in the literature. Our
study describes clinician attitudes surrounding this topic while further demonstrating the
variability in opinions of various clinicians often involved in the care and counseling of these
families. Our results suggest that nearly half of clinicians in our study feel it is appropriate to
discuss the option of cardiac surgery with postnatal physicians and genetic counselors feeling it
is more appropriate for this discussion to take place than prenatal physicians. Of clinicians who
feel this discussion is appropriate, the vast majority are discussing the option of surgery and/or
referring the patient to cardiac surgery for such a discussion to take place. This clinical approach
of discussing cardiac surgery supports recent literature pointing to the fact that cardiac surgery
for infants with trisomy 18 is occurring more frequently than previously reported36. Few
clinicians who responded that the discussion of cardiac surgery is inappropriate still report
discussing and/or referring their patients to cardiac surgery. Interestingly, a quarter of clinicians
felt the discussion was appropriate, however indicated that they do not discuss the option of
cardiac surgery. This suggests there may be barriers that clinicians experience regarding the
discussion of cardiac surgery, however these potential barriers that may exist were not formally
explored in our study. Several respondents stated lack of accessibility to willing surgeons in the
free responses as further explanations for why the option is not offered to their patients;
exploration of this and other barriers is warranted through formal study. Overall, our study
provides evidence that there are clinicians across multiple sub-specialties who feel the
discussion of cardiac surgery is appropriate and report actually having such discussions with
families and referring them to cardiac surgery.
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There is limited research in current literature examining clinician attitudes towards the
use of a wide range of terms to describe individuals with trisomy 18. These terms range from
less patient friendly descriptions such as vegetative, incompatible with life, and lethal anomaly
to the more patient friendly term life-limiting, which were included based on literature regarding
communicating with families about trisomy 18 as well as other severe conditions24, 39-41. While
overall most clinicians disagreed with the less patient friendly terms (vegetative and
incompatible with life) and agreed with the most patient friendly term (life-limiting), prenatal
physicians were more likely to agree with the less sensitive terms when compared to postnatal
physicians and genetic counselors.
One challenge families of infants with trisomy 18 face is the inconsistency between
prenatal and postnatal counseling by their medical team. Our study shows evidence that prenatal
physicians have significantly different perceptions of trisomy 18 compared to our other clinician
groups. We found that prenatal physicians were more likely to agree with use of less patient
friendly terms to describe the prognosis of trisomy 18 (specifically incompatible with life) and
were slightly more likely to indicate infants with trisomy 18 have a shorter lifespan than current
literature supports. Additionally, prenatal physicians were more likely to consider surgery to
have no end benefit and less likely to consider surgery may have the potential to extend time
with infant or improve the infant’s quality of life. Overall, prenatal physicians reported less
support of the discussion of the option of cardiac surgery for these infants compared to postnatal
physicians and genetic counselors. While we cannot ascertain from our study the reason prenatal
physicians responded more unfavorably towards trisomy 18 than postnatal physicians and
genetic counselors, we can speculate based on the nature of the patients and care these clinicians
provide in their respective specialties. For those working with families following a prenatal
diagnosis, 72% of those pregnancies will result in miscarriage or stillbirth42 thus the majority
may feel the discussion of surgery is inappropriate and irrelevant to the majority of the
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pregnancies they encounter due to the high percentage of prenatal and perinatal deaths.
Conversely, postnatal physicians are more likely to encounter the 28% of infants with trisomy
18 who have survived delivery and potentially the neonatal period and thus may represent the
less severely affected cases where potentially the discussion of cardiac surgery is more
appropriate and relevant. These experiences of clinicians may in turn affect the perception of
these clinicians towards trisomy 18 in general and regarding the appropriateness of discussing
the option of cardiac surgery.
In our study, clinician attitudes were examined around common themes that have
emerged in previous literature15-18, 24. These themes included ethical considerations such as
access to interventions, the general high mortality of trisomy 18, potential for pain and suffering
of infant during and post-surgery, high perioperative mortality of surgery, and providing false
hope to the family, as well as other themes including societal costs, insufficient outcome data,
issues surrounding quality of life, and parental autonomy. In general, our study provides
evidence that there is clinician support of the discussion of the option cardiac surgery. However,
many clinicians still expressed discomfort with offering cardiac when considering the lack of
outcome data and reasons surrounding ethical principles such as nonmaleficence, beneficence,
and justice. These findings support and further validate numerous studies15-17 that have
expressed hesitancy in performing or offering cardiac surgery for infants with trisomy 18 when
considering ethical issues and insufficient outcome data. Clinicians indicating that ethical
concerns surrounding offering surgery were justifications against offering surgery was
unsurprising as ethical concerns surrounding this topic are undeniably an important and
recurrent topic in discussions between clinicians and with families when deciding if cardiac
surgery is appropriate24. Dissimilarly, several studies15, 29 have pointed to the societal burden of
performing cardiac surgery for these infants as a clear reason against offering surgery; however
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more clinicians in our study felt surgery should still be offered or were neutral regarding societal
burdens of cardiac surgery than felt societal burdens were a reason against offering surgery.
There was also no consensus among clinicians when asked if insurance companies should cover
the cost of surgery. Therefore, it may be that the potential burden to society that others have
suggested is not uniformly felt by clinicians in our study as a reason not to offer surgery.
The consideration of trisomy 18 not being uniformly lethal was the sole reason upon
which more than half of clinicians agreed cardiac surgery should be offered. This finding is
consistent with a notable shift in the literature emphasizing that trisomy 18 should not be
presented as a lethal anomaly in the counseling of families given the known survivability2, 40, 43.
Previous studies32, 33 have suggested that parental autonomy provides an impact regarding
management decisions made by clinicians, however the results of our study demonstrated mixed
feelings toward parental involvement. Over half of clinicians in this study disagreed or were
neutral regarding expressed parental wishes as a reason to offer cardiac surgery, however, the
great majority of clinicians in our study felt that an end benefit to performing surgery is that
parental autonomy is respected. This implies that clinicians in our study may or may not feel
that parental autonomy sway their decisions to offer cardiac surgery, but they did agree that
parental autonomy had a place as a potential benefit of performing surgery.
Most clinicians “strongly disagreed” with parents alone judging the risk-benefit ratio of
cardiac surgery as a reason to offer cardiac surgery than all other reasons provided. This was
further illustrated by multiple free response comments expressing that allowing parents alone to
weigh the risks and benefits of surgery takes away from the valuable medical expertise and
experience clinicians provide. These findings support the “shared decision making approach”
suggested in previous literature, which describes an approach to care that involves the values
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and wishes of the families as well as the medical knowledge and expertise of clinicians of
multiple subspecialties30.
Our study also aimed to describe cardiac surgeons’ approaches to determining candidacy
for cardiac surgery among infants with trisomy 18. Due to the small number of cardiac surgeons
who participated in this survey, we are unable to draw conclusions but can make general
comments on the responses received from the surgeons in our study. With regard to the heart
defect complexity, as expected, more cardiac surgeons in our study were willing to perform
surgical repair on mild to moderate complex heart defects such as VSDs, PDAs, and
coarctations of the aorta, while less were willing to perform surgery for increasingly complex
heart defects such as transposition of the great arteries and double outlet right ventricle and none
were willing to perform surgery on the complex hypoplastic left heart syndrome. This is
consistent with previous studies11, 19-23 that have described repairs of congenital heart defects in
infants with trisomy 18, suggesting that they are the heart defects most operated on of those
reported. Cardiac surgeons were less likely to be willing to perform surgery in the presence of
additional worsening anomalies such as esophageal atresia and congenital diaphragmatic hernia,
which even when found in isolation have higher postoperative morbidity and mortality
compared to other anomalies such as polydactyly and cleft lip with or without cleft palate44, 45.
Cardiac surgeons indicated that other factors such as gestational age and birth weight were
influential along with the complexity of the heart defect and presence of other anomalies when
considering an infant for cardiac surgery. The specific aspects of gestational age and birth
weight were not described; future studies may allow surgeons to expand upon this further with
insights into their attitudes towards acceptable birth weights and gestational ages at time of
delivery. Overall, these findings suggest cardiac surgeons are most willing to perform surgery
on mild to moderate heart defects in the absence of additional anomalies or presence of
24

additional anomalies associated with lower morbidity rates. Further, our study found that all
cardiac surgeons who responded have either performed surgery or are willing to perform
surgery, demonstrating that the option exists.
Genetic counselors are often involved in both the pre- and postnatal discussions
regarding the care and management for families with a diagnosis of trisomy 18. The overall
findings of this study were that a greater majority of genetic counselors felt the discussion of
cardiac surgery is appropriate compared to physicians. Expressed parental wishes and trisomy
18 not being uniformly lethal were more important considerations reported by genetic
counselors in support of offering surgery, compared to physicians. These findings support basic
tenants of genetic counseling regarding nondirective counseling, providing balanced
perspectives of conditions, supporting patient autonomy and decision making, and advocating
for families. Furthermore, genetic counselors have the skills to initiate psychosocially targeted
conversations with families and they are often able to ascertain the family’s values and wishes
as to better understand the reasoning behind their pursuit of aggressive interventions like cardiac
surgery for their infant. Ascertaining the family’s values and wishes, advocating for patients and
their family as well as placing an importance on patient autonomy highlights the valuable and
unique role genetic counselors play as part of a multidisciplinary team regarding complex
management decisions such as the pursuit of cardiac surgery46.

PRACTICE IMPLICATIONS
Our study demonstrates the differing opinions among clinicians regarding the
appropriateness of offering cardiac surgery. The difference is most notable when comparing
prenatal physicians to postnatal physicians and genetic counselors. The differing opinions
between clinicians overall and specifically with regard to prenatal physicians points to the
importance of open communication among the specialties to ensure that providers are educated
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on how their colleagues are approaching this option with patients. Families should be provided
with balanced and consistent counseling on the decisions surrounding cardiac surgery to avoid
misunderstanding and mistrust17.
While not ascertained in previous literature for comparisons, almost half of the clinicians
in our study indicated that they feel the discussion of cardiac surgery is appropriate and
approximately half of the clinicians self-reported that their approach to discussing the option of
cardiac surgery has changed over time. This suggests that attitudes are not static towards
surgical interventions for infants with trisomy 18 and that there is potential for approaches to
continue to evolve over time. Moreover, all cardiac surgeons in our study were willing to
perform surgery on infants with trisomy 18 depending on the clinical picture of the infant,
which may contradict some clinicians’ beliefs. While limitations exist with the data obtained by
the cardiac surgeons in our study, understanding the willingness and conditions in which cardiac
surgeons will perform surgery is another important aspect to this complex topic that further
points to an evolving attitude.
The goal of this study was not to provide recommendations for uniform care of all
infants with heart defects and trisomy 18, as an individualized approach to care of each patient
is paramount. Results of this study may lead to a heightened appreciation for the complexity of
this issue for clinicians who may perceive cardiac surgery as irrelevant or believe that the barrier
to access surgeons who are willing to perform surgery is so great that it is simply not worth
considering. Our findings support the notion of incorporating at least recognition of the option
of cardiac surgery in the discussion of management of infants with trisomy 18, including an
acknowledgment that this may not be available based on the clinical picture or other centerspecific criteria, as well as giving families permission to not explore or choose this option.
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Appropriate referrals can be provided if the discussion is beyond the clinician’s scope of
practice, knowledge, or comfort.
We hope the results of this study will be shared within and among multidisciplinary
specialists involved in the care of infants with trisomy 18 to improve understanding of current
practice and attitudes. By stimulating such discussions among clinicians, further education and
informed attitudes regarding this topic among themselves and their peers will be accomplished.
We appreciate it is unrealistic to believe clinicians will ever completely agree on offering
surgery or not; however it is reasonable to expect clinicians to collaborate with one another in
the care of families of infants with trisomy 18 in order to promote consistent patient care and
open and honest discussions exploring families’ goals and wishes.
STRENGTHS AND LIMITATIONS
This study was able to describe the attitudes of both prenatal and postnatal clinicians
surrounding their attitudes towards care of infants with trisomy 18. This is a strength of our
study since many clinicians are involved in the care surrounding infants with trisomy 18 during
the pre- and postnatal period, thus we were able to make comparisons. Previous literature has
pointed to the importance for such examinations before further progress on this topic can be
made35, 36, 38. Our study design also allowed for sampling attitudes of physicians throughout the
country in the specialties of maternal fetal medicine and genetic counseling which aids to the
applicability of these results.
The sampling of physicians through fetal centers may have led to attitudes mostly
representative of physicians in medical centers with access to more cutting edge technology and
colleagues who are more likely to be in an academic setting practicing standards of care based
on current literature. Therefore, our physician population (excluding MFMs) is not
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representative of physicians at large, but rather more likely representative of physicians in an
academic setting.
Sample sizes for some of our physician groups were a limitation as well. While the
postnatal physician group captured a wide spectrum of the physicians involved in the care of
infants with trisomy 18 in the postnatal period, the prenatal physician group consisted mostly of
MFMs (n=72) and few OBGYNs (n=3). Therefore, the results of this study and the attitudes of
the prenatal physicians should be interpreted to be mostly representative of MFMs and cannot
be extrapolated to the attitudes of OBGYNs. Our study does represent a broad sample of MFMs
which is valuable since MFMs are important clinicians in high-risk pregnancies such as those
diagnosed with trisomy 18. However, we cannot comment extensively on the attitudes of
OBGYNs who, depending on the circumstance, may be the initial and possibly only contact for
families when a diagnosis of trisomy 18 is suspected or confirmed. Therefore, this is a limitation
of our study. Similarly, the six cardiac surgeons who responded to our survey practice either in
Texas (n=4) or Missouri (n=2). Therefore, the attitudes of the cardiac surgeons in our study
cannot be extrapolated to be representative of the attitudes and opinions of cardiac surgeons in
general. This is, again, a limitation of our study as one of the aims was to comment further on
the opinions of cardiac surgeons and the influential variables in determining surgical candidacy
for infants with trisomy 18, however based on our small sample size, we are limited to sharing
our findings and not drawing conclusions.
Another limitation that is common to survey research is selection bias. The clinicians
who participated in our study may be those who feel most strongly about this topic and may not
represent the average clinician. Additionally, although we have reported qualitative assessments
of the free responses, it should be noted that our survey was not designed as a qualitative free
response study. Therefore, it is possible the responses were biased by the questions preceding
them.
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Lastly, at times the term “cardiac intervention” was used in the survey which was
intended to be synonymous with cardiac surgery, however upon closer consideration could have
been interpreted as palliative surgical interventions, such as pulmonary artery banding, not
exclusively surgical repair47. While most often the actual phrase “cardiac surgery” was used, the
following questions used “cardiac intervention”: appropriateness to discuss the option,
appropriateness for insurance companies to cover cost, discussion is within scope of practice,
“end benefit” questions, factors that have influenced clinicians’ recommendations, and
questions regarding clinicians’ approaches to such discussion. Overall, we do not feel this
discrepancy in wording heavily impacted the results and conclusions drawn from our study.
FUTURE DIRECTIONS
While our study was able to capture a variety of pre- and postnatal clinicians that are
involved in care of these infants, the opinions of other clinicians such as pediatricians, nurses,
and social workers would be a valuable addition to the literature in an effort to obtained
inclusive data on the attitudes of the many clinicians involved to better understand the
perspective of the different specialties. This would ultimately better serve families encountering
this decision-making process in the future. Continued research is also needed on the cardiac
conditions and influential variables impacting surgical treatment in a larger population of
cardiac surgeons to better describe how these decisions are made. Finally, if current trends
continue and more families are offered and pursue the option of surgery, longitudinal research
should be done to assess these outcomes as well as the experiences of the families. This will
provide necessary information to those clinicians still hesitant to broach this topic based on
insufficient research on outcomes and will also provide better understanding of clinician and
family interactions.
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APPENDIX

Q1 Age
m 18 - 24
m 25 - 34
m 35 - 44
m 45 - 54
m 55 - 64
m 65 - 74
m 75 or older
Q2 Gender
m Male
m Female
Q3 Race/Ethnicity
m White
m Black or African American
m American Indian or Alaska Native
m Asian
m Native Hawaiian or Pacific Islander
m Other
Q4 In what state do you currently practice?
(select state from drop down menu)
Q5 Setting of practice
m University based hospital practice
m Non-university hospital practice
m Private practice
m Other, please specify ____________________
Q6 How many years have you been in your current specialty?
m less than 5 years
m 5 to 10 years
m 11 to 15 years
m 16 to 20 years
m more than 20 years
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Q7 What is your specialty?
m Obstetrics and Gynecology (skip to Q8)
m Maternal Fetal Medicine (skip to Q8)
m Neonatology (skip to Q23)
m Medical Genetics (skip to Q23)
m Genetic Counseling (skip to Q38)
m Cardiology (skip to Q23)
m Cardiothoracic surgery (skip to Q54)
m Other, please specify ____________________ (skip to Q8)
Q8 How many years since you have received your medical degree?
m less than 5 years
m 5 to 10 years
m 11 to 15 years
m 16 to 20 years
m more than 20 years
Q9 Please select from the choices provided your understanding of the postnatal lifespan
of patients with non-mosaic trisomy 18:
m No infants survive beyond one year
m <1% survive beyond one year
m 5-10% survive beyond one year
m 20-25% survive beyond one year
m I do not know
Q10 How many patients with a prenatal diagnosis of trisomy 18, on average per year,
have you participated in care for?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
m Not sure
Q11 How many patients with a prenatal diagnosis of trisomy 18, on average per year,
have you discussed cardiac intervention as a postnatal option?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
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m Not sure
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18
and cardiac intervention. Please remember to consider each question in regards to a
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.
Q12 Please indicate for each of the following terms below whether you agree or disagree
with the term being used to describe patients with trisomy 18.
Strongly
Disagree Neutral Agree
Strongly
Disagree
agree
Life-limiting
Vegetative
Incompatible with
life

m
m

m
m

m
m

m
m

m
m

m

m

m

m

m

Lethal anomaly

m

m

m

m

m

Q13 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion
on the following statements below.
Strongly Disagree Neutral Agree Strongly
disagree
agree
It is appropriate to counsel families
with an infant with trisomy 18 and
m
m
m
m
m
a cardiac defect about the option of
cardiac intervention.
It is appropriate for insurance
companies to cover the cost of
m
m
m
m
m
cardiac intervention for infants with
trisomy 18.
Discussing the option of cardiac
intervention for infants with a
m
m
m
m
m
prenatal diagnosis of trisomy 18 is
within my scope of practice.
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Q14 The below reasons have been given for NOT providing cardiac surgery on infants
with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please indicate
your feelings toward each statement.
Surgery should not be offered to infants with trisomy 18 because…
Strongly
disagree
Trisomy 18 is associated with
unacceptably high mortality.
It is an inappropriate allocation of
the institution's time and resources.
Because the perioperative
mortality is unacceptably high in
these infants.

Disagree Neutral Agree

Strongly
agree

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

Surgery causes the infant pain and
suffering.

m

m

m

m

m

It provides false hope for the
family.

m

m

m

m

m

Surgery results in prolonging
short-term life but does not
produce a cure or affect long-term
survival.
The cost to society for the infants
to undergo surgery is burdensome.
Surgery will not improve the
quality of the infant's life.
There is insufficient research done
examining the risks and benefits to
the infant.
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Q15 Additional reasons you feel cardiac surgery SHOULD NOT be performed on an
infant with trisomy 18, if any.
(open response text box)
Q16 The below reasons have been given in SUPPORT of providing cardiac surgery on
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please
indicate your feelings toward each statement.
Surgery should be offered to infants with trisomy 18…
Strongly Disagree Neutral Agree
disagree
If the parents express their desire to
have "everything done" for their
m
m
m
m
child.
Because the infant deserves the
opportunity for the same
interventions offered to other
chromosomally normal infants with
congenital heart defects.
Because surgery may improve the
infant's quality of life.
Because trisomy 18 is not uniformly
lethal.
Because infants with trisomy 18 can
have an acceptable quality of life.
Because parent(s) alone should
judge risk-benefit ratio for surgery.

Strongly
agree
m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

Q17 Additional reasons you feel cardiac surgery SHOULD be performed on an infant
with trisomy 18, if any.
(open response text box)
Q18 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of
this intervention is:
No end benefit
Parental wishes/autonomy are
honored
Potential for extended time with
infant
Potential for improved quality of
life
Other, please specify

Disagree
m

Agree
m

m

m

m

m

m

m

m

m
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Q19 Which factors have influenced your recommendations towards cardiac intervention
for infants with trisomy 18? (check all that apply)
q Medical school training
q First hand clinical experience
q Discussion with colleagues
q Parental autonomy
q Other, please specify ____________________
Q20 Please describe your approach to discussing the option of cardiac intervention for
infants with trisomy 18.
m I do not discuss the option of cardiac intervention.
m I will discuss it if brought up by the parents, but I emphasize intervention is
discouraged.
m I will discuss it if brought up by the parents, emphasize it may be an option, but do
not refer to cardiac surgery.
m I will discuss it if brought up by the parents, emphasize it may be an option, and refer
to cardiac surgery.
m I discuss it in all cases regardless if brought up by parents.
m Other, please specify ____________________
Q21 If your approach to discussing cardiac intervention has changed over time, what has
influenced this? (check all that apply)
q My approach has not changed.
q New literature on this topic
q Discussions with my colleagues
q First hand clinical experiences
q Other, please specify ____________________
Q22 Any additional comments you have on this subject of trisomy 18 and cardiac
intervention would be helpful.
(open response text box)
END OF SURVEY
Q23 How many years since you have received your medical degree?
m less than 5 years
m 5 to 10 years
m 11 to 15 years
m 16 to 20 years
m more than 20 years
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Q24 Please select from the choices provided your understanding of the postnatal lifespan
of patients with non-mosaic trisomy 18:
m No infants survive beyond one year
m <1% survive beyond one year
m 5-10% survive beyond one year
m 20-25% survive beyond one year
m I do not know
Q25 How many patients with a diagnosis of trisomy 18, on average per year, have you
participated in care for?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
m Not sure

Q26 How many patients with a diagnosis of trisomy 18, on average per year, have you
discussed cardiac intervention as a postnatal option?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
m Not sure
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18
and cardiac intervention. Please remember to consider each question in regards to a
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.
Q27 Please indicate for each of the following terms below whether you agree or disagree
with the term being used to describe patients with trisomy 18.
Strongly
Disagree Neutral Agree
Strongly
Disagree
agree
Life-limiting
Vegetative
Incompatible with
life
Lethal anomaly

m
m

m
m

m
m

m
m

m
m

m

m

m

m

m

m

m

m

m

m
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Q28 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion
on the following statements below.
Strongly Disagree Neutral Agree Strongly
disagree
agree
It is appropriate to counsel families
with an infant with trisomy 18 and
m
m
m
m
m
a cardiac defect about the option of
cardiac intervention.
It is appropriate for insurance
companies to cover the cost of
cardiac intervention for infants with
trisomy 18.

m

m

m

m

m

Discussing the option of cardiac
intervention for infants with a
diagnosis of trisomy 18 is within
my scope of practice.

m

m

m

m

m

Q29 The below responses have been given for NOT providing cardiac surgery on infants
with trisomy 18. On a scale to "strongly disagree" to "strongly agree", please indicate
your feelings toward each statement.
Surgery should not be offered to infants with trisomy 18 because…
Strongly Disagree Neutral Agree
disagree
Trisomy 18 is associated with
unacceptably high mortality.

Strongly
agree

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

Surgery results in prolonging
short-term life but does not
produce a cure or affect long-term
survival.

m

m

m

m

m

The cost to society for the infants
to undergo surgery is burdensome.

m

m

m

m

m

Surgery will not improve the
quality of the infant's life.

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

It is an inappropriate allocation of
the institution's time and resources.
Because the perioperative
mortality is unacceptably high in
these infants.

There is insufficient research done
examining the risks and benefits to
the infant.
Surgery causes the infant pain and
suffering.
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It provides false hope for the
family.

m

m

m

m

m

Q30 Additional reasons you feel cardiac surgery SHOULD NOT be performed on an
infant with trisomy 18, if any.
(open response text box)
Q31 The below reasons have been given in SUPPORT of providing cardiac surgery on
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please
indicate your feelings toward each statement.
Surgery should be offered to infants with trisomy 18…
Strongly Disagree Neutral Agree Strongly
disagree
agree
If the parents express their desire to
have "everything done" for their
m
m
m
m
m
child.
Because the infant deserves the
opportunity for the same
interventions offered to other
chromosomally normal infants with
congenital heart defects.
Because trisomy 18 is not uniformly
lethal.
Because infants can have an
acceptable quality of life.
Because parent(s) alone should
judge risk-benefit ratio for surgery.

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

Q32 Additional reasons you feel cardiac surgery SHOULD be performed on an infant
with trisomy 18, if any.
(open response text box)
Q33 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of
this intervention is:
Disagree
Agree
No end benefit
m
m
Parental wishes/autonomy are
m
m
honored
Potential for extended time with
m
m
infant
Potential for improved quality
m
m
of life
Other, please specify
m
m
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Q34 Which factors have influenced your recommendations towards cardiac intervention
for infants with trisomy 18? (check all that apply)
q Medical school training
q First hand clinical experience
q Discussion with colleagues
q Parental autonomy
q Other, please specify ____________________
Q35 Please describe your approach to discussing the option of cardiac intervention for
infants with trisomy 18.
m I do not discuss the option of cardiac intervention.
m I will discuss it if brought up by the parents, but I emphasize intervention is
discouraged.
m I will discuss it if brought up by the parents, emphasize it may be an option, but do
not refer to cardiac surgery.
m I will discuss it if brought up by the parents, emphasize it may be an option, and refer
to cardiac surgery.
m I discuss it in all cases regardless if brought up by the parents.
m Other, please specify ____________________
Q36 If your approach to discussing the option of cardiac intervention has changed over
time, what has influenced this? (check all that apply)
q My approach has not changed.
q New literature on this topic
q Discussions with my colleagues
q First hand clinical experiences
q Other, please specify ____________________
Q37 Any additional comments you have on this subject of trisomy 18 and cardiac
intervention would be helpful.
(open response text box)
END OF SURVEY
Q38 How many years since you have received your master’s in genetic counseling?
m less than 5 years
m 5 to 10 years
m 11 to 15 years
m 16 to 20 years
m more than 20 years
Q39 Please select all that apply regarding your current subspecialty in genetic
counseling.
m Preconception/Prenatal
m Pediatrics/Medical Genetics
m Other, please specify __________
39

Q40 Please select from the choices provided your understanding of the postnatal lifespan
of patients with non-mosaic trisomy 18:
m No infants survive beyond one year
m <1% survive beyond one year
m 5-10% survive beyond one year
m 20-25% survive beyond one year
m I do not know
Q41 How many patients with a prenatal diagnosis of trisomy 18, on average per year,
have you participated in care for?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
m Not sure
Q42 How many patients with a prenatal diagnosis of trisomy 18, on average per year,
have you discussed cardiac intervention as a postnatal option?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
m Not sure
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18
and cardiac intervention. Please remember to consider each question in regards to a
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.
Q43 Please indicate for each of the following terms below whether you agree or disagree
with the term being used to describe patients with trisomy 18.
Strongly
Disagree Neutral Agree
Strongly
Disagree
agree
Life-limiting
Vegetative
Incompatible with
life
Lethal anomaly

m
m

m
m

m
m

m
m

m
m

m

m

m

m

m

m

m

m

m

m
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Q44 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion
on the following statements below.
Strongly Disagree Neutral Agree Strongly
disagree
agree
It is appropriate to counsel families
with an infant with trisomy 18 and
m
m
m
m
m
a cardiac defect about the option of
cardiac intervention.
It is appropriate for insurance
companies to cover the cost of
m
cardiac intervention for infants with
trisomy 18.

m

m

m

m

Discussing the option of cardiac
intervention for infants with a
prenatal diagnosis of trisomy 18 is
within my scope of practice.

m

m

m

m

m

Q45 The below reasons have been given for NOT providing cardiac surgery on infants
with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please indicate
your feelings toward each statement.
Surgery should not be offered to infants with trisomy 18 because…
Strongly
Disagree Neutral Agree
disagree
Trisomy 18 is associated with
unacceptably high mortality.
It is an inappropriate allocation of
the institution's time and
resources.
Because the perioperative
mortality is unacceptably high in
these infants.
The cost to society for the infants
to undergo surgery is
burdensome.
Surgery will not improve the
quality of the infant's life.
There is insufficient research
done examining the risks and
benefits to the infant.
Surgery causes the infant pain and
suffering.
It provides false hope for the
family.

Strongly
agree

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m
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Q46 Additional reasons you feel cardiac surgery SHOULD NOT be performed on an
infant with trisomy 18, if any.
(open response text box)
Q47 The below reasons have been given in SUPPORT of providing cardiac surgery on
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please
indicate your feelings toward each statement.
Surgery should be offered to infants with trisomy 18…
Strongly Disagree Neutral Agree
disagree
If the parents express their desire to
have "everything done" for their
m
m
m
m
child.
Because the infant deserves the
opportunity for the same
interventions offered to other
chromosomally normal infants with
congenital heart defects.
Because trisomy 18 is not uniformly
lethal.
Because infants with trisomy 18 can
have an acceptable quality of life.
Because parent(s) alone should
judge risk-benefit ratio for surgery.

Strongly
agree
m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

Q48 Additional reasons you feel cardiac surgery SHOULD be performed on an infant
with trisomy 18, if any.
(open response text box)
Q49 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of
this intervention is:

No end benefit
Parental wishes/autonomy
are honored
Potential for extended time
with infant
Potential for improved
quality of life
Other, please specify

Disagree
m

Agree
m

m

m

m

m

m

m

m

m

Q50 Which factors have influenced your recommendations towards cardiac intervention
for infants with trisomy 18? (check all that apply)
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q
q
q
q
q

Genetic counseling school training
First hand clinical experience
Discussion with colleagues
Parental autonomy
Other, please specify ____________________

Q51 Please describe your approach to discussing the option of cardiac intervention for
infants with trisomy 18.
m I do not discuss the option of cardiac intervention.
m I will discuss it if brought up by the parents, but I emphasize intervention is
discouraged.
m I will discuss it if brought up by the parents, emphasize it may be an option, but do
not refer to cardiac surgery.
m I will discuss it if brought up by the parents, emphasize it may be an option, and refer
to cardiac surgery.
m I discuss it in all cases regardless if brought up by parents.
m Other, please specify ____________________
Q53 Any additional comments you have on this subject of trisomy 18 and cardiac
intervention would be helpful.
(open response text box)
END OF SURVEY
Q54 Please select all that apply regarding your subspecialty in cardiothoracic surgery.
m Adult cardiac surgery
m Thoracic surgery
m Congenital heart surgery
m Other, please specify __________
Q55 Please select from the choices provided your understanding of the postnatal lifespan
of patients with non-mosaic trisomy 18:
m No infants survive beyond one year
m <1% survive beyond one year
m 5-10% survive beyond one year
m 20-25% survive beyond one year
m I do not know
Q56 How many patients with a diagnosis of trisomy 18, on average per year, have you
participated in care for?
m None
m 1-5
m 6-10
m 11-15
m 16-20
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m 21 or more
m Not sure
Q57 Of the patients with a diagnosis of trisomy 18 that you have participated in care for,
on average per year, how many have undergone cardiac surgery on average per year?
m None
m 1-5
m 6-10
m 11-15
m 16-20
m 21 or more
m Not sure
Q58 Most patients with trisomy 18 for whom I provide consultation are:
m Referred by their doctor
m Self-referred
m Other, please specify ____________________
Q59 Most patients with trisomy 18 for whom I provide consultation are:
m Currently pregnant
m Postnatal with a prenatal diagnosis of trisomy 18
m Postnatal with a postnatal diagnosis of trisomy 18
m Other, please specify ____________________

The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18
and cardiac intervention. Please remember to consider each question in regards to a
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.
Q60 Please indicate for each of the following terms below whether you agree or disagree
with the term being used to describe patients with trisomy 18.
Strongly
Disagree Neutral Agree
Strongly
Disagree
agree
Life-limiting
m
m
m
m
m
Vegetative
Incompatible with
life
Lethal anomaly

m

m

m

m

m

m

m

m

m

m

m

m

m

m

m

Q61 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion
on the following statements below.
Strongly Disagree Neutral Agree Strongly
disagree
agree
It is appropriate to counsel families
m
m
m
m
m
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with an infant with trisomy 18 and
a cardiac defect about the option of
cardiac intervention.
It is appropriate for insurance
companies to cover the cost of
cardiac intervention for infants with
trisomy 18.
Discussing the option of cardiac
intervention for infants with a
diagnosis of trisomy 18 is within
my scope of practice.

m

m

m

m

m

m

m

m

m

m

Q62 The below reasons have been given for NOT providing cardiac surgery on infants
with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please indicate
your feelings toward each statement.
Surgery should not be offered to infants with trisomy 18 because…
Strongly Disagree Neutral Agree Strongly
disagree
agree
Trisomy 18 is associated with
m
m
m
m
unacceptably high mortality.
It is an inappropriate allocation of the
m
m
m
m
institution's time and resources.
The perioperative mortality is
m
m
m
m
unacceptably high in these infants.
The cost to society for the infants to
m
m
m
m
undergo surgery is burdensome.
Surgery will not improve the quality of
m
m
m
m
the infant's life.
There is insufficient research done
examining the risks and benefits to the
m
m
m
m
infant.
Q
Surgery causes the infant pain and
m
m
m
m
6suffering.
3
Surgery provides false hope for the
m
m
m
m
family.
A
dditional reasons you feel cardiac surgery SHOULD NOT be performed on an infant
with trisomy 18, if any.
(open response text box)
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m
m
m
m
m
m
m
m

Q64 The below reasons have been given in SUPPORT of providing cardiac surgery on
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please
indicate your feelings toward each statement.
Surgery should be offered to infants with trisomy 18…
Strongly Disagree Neutral Agree
disagree
If the parents express their desire to
have "everything done" for their
m
m
m
m
child.
Because the infant deserves the
opportunity for the same
interventions offered to other
chromosomally normal infants with
congenital heart defects.

m

m

m

m

Strongly
agree
m

m

Because trisomy 18 is not uniformly
m
m
m
m
m
lethal.
Because infants can have an
m
m
m
m
m
acceptable quality of life.
Because parent(s) alone should
m
m
m
m
m
judge risk-benefit ratio for surgery.
Q65 Additional reasons you feel cardiac surgery SHOULD be performed on an infant
with trisomy 18, if any.
(open response text box)
Q66 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of
this intervention is:

There is no end benefit
Parental wishes/autonomy are
honored
Potential for extended time with
infant
Potential for improved quality of
life
Other, please specify

Disagree
m

Agree
m

m

m

m

m

m

m

m

m
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Q67 How is your decision made whether or not to perform cardiac intervention for
infants with trisomy 18? (check all that apply)
q I never perform cardiac intervention for infants with trisomy 18.
q I perform cardiac intervention for all infants with trisomy 18.
q I make the decision on a case-by-case basis.
q The decision is made at the discretion of the attending team.
q There is a defined protocol at my institution that I abide by.
q Other, please specify ____________________
Q68 If your approach to performing cardiac intervention to infants with trisomy 18 has
changed over time, what has influenced this? (check all that apply)
q My approach has not changed.
q New literature on this topic
q Discussions with my colleagues
q First hand clinical experiences
q Other, please specify ____________________
Q69 Please rank the following factors that have influenced your approach towards
cardiac intervention for infants with trisomy 18
(1 most influential to 4 least influential)
______ Medical school training
______ First hand clinical experience
______ Discussion with colleagues
______ Parental autonomy
Q70 Have you performed cardiac surgery on an infant with trisomy 18?
m Yes (If yes go to Q73)
m No (If no go to Q71)
Q71 Would you ever consider performing cardiac surgery on an infant with trisomy 18?
m Yes (If yes go to Q73)
m No (If no go to Q72)
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Q72 Please expand on your reasoning behind never considering performing cardiac
surgery on an infant with trisomy 18.
(open text box)
END OF SURVEY
Q73 Please indicate which heart defects for infants with trisomy 18 you would operate
on, in the absence of additional congenital defects:
Yes No
Atrial Septal Defect
Ventricular Septal Defect

m
m

m
m

Patent Ductus Arteriosus
Coarctation of the Aorta

m
m

m
m

Tetralogy of Fallot
Atrioventricular Septal Defect
Hypoplastic Left Heart

m
m
m

m
m
m

Double Outlet Right Ventricle
Pulmonary Stenosis

m
m

m
m

Transposition of the Great Arteries m
Other, please specify
m

m
m

Q74 Please indicate on a scale of "not at all influential" to "very influential" which of the
following factors influence your decision when determining if an infant with trisomy 18
is a good surgical candidate for cardiac surgery.
Not at all
Somewhat
Very
influential
influential
influential
Gender
m
m
m
Gestational age
Birth weight

m
m

m
m

m
m

Apgar scores of infant
Presence of additional anomalies

m
m

m
m

m
m

Complexity of heart defect
Parental request
Support of other healthcare team
members
Recommendation of bioethics
committee
Other, please specify

m
m

m
m

m
m

m

m

m

m

m

m

m

m

m
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Q75 In an infant with trisomy 18 with a heart defect present of mild to moderate
complexity, the additional presence of which of the below birth defects would preclude
an infant from surgery:
Would still
perform surgery

Cleft lip/palate
Omphalocele

m
m

Would no
longer
perform
surgery
m
m

Esophageal atresia with or without
tracheoesophageal fistula

m

m

Club foot
Congenital diaphragmatic hernia
Spina bifida

m
m
m

m
m
m

Polydactyly

m

m

Q76 Any additional comments on trisomy 18 and cardiac intervention would be helpful.
(open response text box)
END OF SURVEY
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